PYY(1-36) is the major form of PYY in rat distal small intestine: Quantification using high-resolution mass spectrometry

Regulatory Peptides

Volumn 165, Issue 2-3, 2010, Pages 151-157

  Keire, David A ^a,b   Whitelegge, Julian P ^c   Souda, Puneet ^c   Faull, Kym F ^c   Bassilian, Sara ^a,b   Reidelberger, Roger D ^d,e   Haver, Alvin C ^d   Reeve Jr , Joseph R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^e CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastrointestinal peptides; Gly extended; Intestinal mucosa; PYY(3 36)

Indexed keywords

ALANINE; CARBON 13; PEPTIDE YY; PEPTIDE YY [3-36];

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HORMONE SYNTHESIS; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROCESS MONITORING; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY; SMALL INTESTINE; TISSUE DISTRIBUTION;

ANIMALS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MASS SPECTROMETRY; PEPTIDE YY; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 78649841085     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.06.006     Document Type: Article

References (39)

1. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA 1982, 79:2514-2518.
2. Tatemoto K., Mutt V. Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 1980, 285:417-418.
3. Jin H., Cai L., Lee K., Chang T.M., Li P., Wagner D., Chey W.Y. A physiological role of peptide YY on exocrine pancreatic secretion in rats. Gastroenterology 1993, 105:208-215.
4. Chelikani P.K., Haver A.C., Reidelberger R.D. Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 2004, 287:R1064-R1070.
5. Witte A.B., Gryback P., Holst J.J., Hilsted L., Hellstrom P.M., Jacobsson H., Schmidt P.T. Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man. Regul Pept 2009, 158:57-62.
6. Adrian T.E., Savage A.P., Sagor G.R., Allen J.M., Bacarese-Hamilton A.J., Tatemoto K., Polak J.M., Bloom S.R. Effect of peptide YY on gastric, pancreatic and biliary functions in humans. Gastroenterology 1985, 89:494-499.
7. Greeley G.H., Guo Y.S., Gomez G., Lluis F., Singh P., Thompson J.C. Inhibition of gastric acid secretion by peptide YY is independent of gastric somatostatin release in the rat. Proc Soc Exp Biol Med 1988, 189:325-328.
8. Lloyd K.C., Grandt D., Aurang K., Eysselein V.E., Schimiczek M., Reeve J. Inhibitory effect of PYY on vagally stimulated acid secretion is mediated predominantly by Y1 receptors. Am J Physiol 1996, 270:G123-G127.
9. Bischoff A., Michel M.C. Neuropeptide Y lowers blood glucose in anaesthetized rats via a Y5 receptor subtype. Endocrinology 1998, 139:3018-3021.
10. Lundberg J.M., Tatemoto K., Terenius L., Hellstrom P.M., Mutt V., Hokfelt T., Hamberger B. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA 1982, 79:4471-4475.
11. Eberlein G.A., Eysselein V.E., Schaeffer M., Layer P., Grandt D., Goebell H., Niebel W., Davis M., Lee T.D., Shively J.E., Reeve J.R.J. A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36). Peptides 1989, 10:797-803.
12. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., Wren A.M., Brynes A.E., Low M.J., Ghatei M.A., Cone R.D., Bloom S.R. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418:650-654.
13. Adams S.H., Won W.B., Schonhoff S.E., Leiter A.B., Paterniti J.R. Effects of PYY[3-36] on short-term food intake in mice are not affected by prevailing plasma ghrelin levels. Endocrinology 2004.
14. Chelikani P.K., Haver A.C., Reeve J.R., Keire D.A., Reidelberger R.D. Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats. Am J Physiol Regul Integr Comp Physiol 2006, 290:R298-R305.
15. Chelikani P.K., Haver A.C., Reidelberger R.D. Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology 2005, 146:879-888.
16. Chelikani P.K., Haver A.C., Reidelberger R.D. Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats. Am J Physiol Regul Integr Comp Physiol 2007, 293:R39-R46.
17. Gura T. Obesity research. New data on appetite-suppressing peptide challenge critics. Science 2004, 306:1453-1454.
18. Halatchev I.G., Ellacott K.L., Fan W., Cone R.D. Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology 2004, 145:2585-2590.
19. Koegler F.H., Enriori P.J., Billes S.K., Takahashi D.L., Martin M.S., Clark R.L., Evans A.E., Grove K.L., Cameron J.L., Cowley M.A. Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques. Diabetes 2005, 54:3198-3204.
20. Moran T.H., Smedh U., Kinzig K.P., Scott K.A., Knipp S., Ladenheim E.E. Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 2005, 288:R384-R388.
21. Reidelberger R.D., Haver A.C., Chelikani P.K., Buescher J.L. Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol 2008, 295:R449-R458.
22. Roth C.L., Enriori P.J., Harz K., Woelfle J., Cowley M.A., Reinehr T. Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss. J Clin Endocrinol Metab 2005, 90:6386-6391.
23. Sloth B., Holst J.J., Flint A., Gregersen N.T., Astrup A. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am J Physiol Endocrinol Metab 2007, 292:E1062-E1068.
24. Vrang N., Madsen A.N., Tang-Christensen M., Hansen G., Larsen P.J. PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2006, 291:R367-R375.
25. Keire D.A., Whitelegge J.P., Bassilian S., Faull K.F., Wiggins B.W., Mehdizadeh O.B., Reidelberger R.D., Haver A.C., Sayegh A.I., Reeve J.R. A new endogenous form of PYY isolated from canine ileum: Gly-extended PYY(1-36). Regul Pept 2008, 151:61-70.
26. Steiner D.F., Rouille Y., Gong Q., Martin S., Carroll R., Chan S.J. The role of prohormone convertases in insulin biosynthesis: evidence for inherited defects in their action in man and experimental animals. Diab Metab 1996, 22:94-104.
27. Rawdon B.B., Larsson L.I. Development of hormonal peptides and processing enzymes in the embryonic avian pancreas with special reference to co-localisation. Histochem Cell Biol 2000, 114:105-112.
28. Eipper B.A., Mains R.E., Glembotski C.C. Identification in pituitary tissue of a peptide alpha-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid. Proc Natl Acad Sci USA 1983, 80:5144-5148.
29. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985, 89:1070-1077.
30. Miyachi Y., Jitsuishi W., Miyoshi A., Fujita S., Mizuchi A., Tatemoto K. The distribution of polypeptide YY-like immunoreactivity in rat tissues. Endocrinology 1986, 118:2163-2167.
31. Roddy D.R., Koch T.R., Reilly W.M., Carney J.A., Go V.L. Identification and distribution of immunoreactive peptide YY in the human, canine, and murine gastrointestinal tracts: species-related antibody recognition differences. Regul Pept 1987, 18:201-212.
32. Grandt D., Schimiczek M., Beglinger C., Layer P., Goebell H., Eysselein V.E., Reeve J.R.J. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 1994, 51:151-159.
33. Grandt D., Schimiczek M., Struk K., Shively J., Eysselein V.E., Goebell H., Reeve J. Characterization of two forms of peptide YY, PYY(1-36) and PYY(3-36), in the rabbit. Peptides 1994, 15:815-820.
34. Eysselein V.E., Eberlein G.A., Grandt D., Schaeffer M., Zehres B., Behn U., Schaefer D., Goebell H., Davis M., Lee T.D., et al. Structural characterization of canine PYY. Peptides 1990, 11:111-116.
35. Stengel A., Keire D., Goebel M., Evilevitch L., Wiggins B., Tache Y., Reeve J.R. The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology 2009, 150:5113-5118.
36. Du Y., Parks B.A., Sohn S., Kwast K.E., Kelleher N.L. Top-down approaches for measuring expression ratios of intact yeast proteins using Fourier transform mass spectrometry. Anal Chem 2006, 78:686-694.
37. Pesavento J.J., Mizzen C.A., Kelleher N.L. Quantitative analysis of modified proteins and their positional isomers by tandem mass spectrometry: human histone H4. Anal Chem 2006, 78:4271-4280.
38. Aponte G.W., Park K., Hess R., Garcia R., Taylor I.L. Meal-induced peptide tyrosine tyrosine inhibition of pancreatic secretion in the rat. FASEB J 1989, 3:1949-1955.
39. Greeley G.H., Hill F.L., Spannagel A., Thompson J.C. Distribution of peptide YY in the gastrointestinal tract of the rat, dog, and monkey. Regul Pept 1987, 19:365-372.